Korea S.E.
06:00:00 2024-04-04 pm EDT
5-day change
1st Jan Change
415
KRW
-5.25%
-.--%
-0.72%
Eone Diagnomics Genome Center Co., Ltd. announced that it has received KRW 6 billion in funding from Shinhan Financial Investment Co., Ltd., Samsung Securities Co., Ltd., Mirae Asset Securities Co., Ltd., KB Securities Co., Ltd.
On April 27, 2022, Eone Diagnomics Genome Center Co., Ltd. closed the transaction.
Eone Diagnomics Genome Center Co., Ltd.(KOSDAQ:A245620) dropped from S&P Global BMI Index
Apr. 15
CI
Eone Diagnomics Genome Center Co., Ltd. announced that it has received KRW 20 billion in funding
Apr. 07
CI
Eone Diagnomics Genome Center Co., Ltd. announced that it expects to receive KRW 20 billion in funding
Mar. 21
CI
Eone Diagnomics Genome Center Co., Ltd. acquired GDxLab, INC.
23-10-24
CI
Eone Diagnomics Genome Center to Raise 89.4 Billion Won via Stock Sale
23-08-21
MT
Eone Diagnomics Genome Center Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
23-05-15
CI
Eone Diagnomics Genome Center Co., Ltd. announced that it has received KRW 6 billion in funding from Shinhan Financial Investment Co., Ltd., Samsung Securities Co., Ltd., Mirae Asset Securities Co., Ltd., KB Securities Co., Ltd.
22-04-26
CI
Eone Diagnomics Genome Center Co., Ltd. announced that it expects to receive KRW 6 billion in funding from Shinhan Financial Investment Co., Ltd., Samsung Securities Co., Ltd., Mirae Asset Securities Co., Ltd., KB Securities Co., Ltd.
22-04-21
CI
MarketScreener's World Press Review : April 11, 2022
22-04-11
Eone Diagnomics Genome Center Co., Ltd. announced that it has received KRW 10 billion in funding from Korea Investment Hanwha Healthcare Private Equity Fund Co. Ltd
21-12-09
CI
Eone Diagnomics Genome Center Co., Ltd. announced that it expects to receive KRW 10 billion in funding from Korea Investment Hanwha Healthcare Private Equity Fund Co. Ltd
21-11-28
CI
Eone Diagnomics Genome Center Co., Ltd. announced that it has received KRW 30 billion in funding
21-10-28
CI
Eone Diagnomics Genome Center Co., Ltd. announced that it expects to receive KRW 30 billion in funding
21-10-26
CI
Eone Diagnomics Genome Center Co., Ltd. acquired Natural Life Nutrition Inc.
21-07-27
CI
Maple Holdings Co., Ltd. announced that it has received KRW 25 billion in funding from Eone Diagnomics Genome Center Co., Ltd.
21-07-18
CI
Eone Diagnomics Genome Center Co.Ltd. agreed to acquire remaining 51.07% stake in EDGC Healthcare Co., Ltd for approximately KRW 140 billion.
20-05-24
CI
Eone Diagnomics Genome Center : South Korean test kit makers swamped as coronavirus cases explode in U.S., Europe
20-03-27
RE
Eone Diagnomics Genome Center Co.Ltd. announced that it has received KRW 20 billion in funding from Mirae Asset Daewoo Co., Ltd., AJU IB INVESTMENT Co., Ltd., Korea Investment & Securities Co., Ltd., Investment Arm, NH Investment & Securities Co., Ltd.
19-06-30
CI
Eone Diagnomics Genome Center Co.Ltd. to Raise USD 17.2 Million in Private Placement of Bonds
19-06-24
CI
Eone Diagnomics Genome Center Co.Ltd. announced that it expects to receive KRW 20 billion in funding from Mirae Asset Daewoo Co., Ltd., AJU IB INVESTMENT Co., Ltd., Korea Investment & Securities Co., Ltd., Investment Arm, NH Investment & Securities Co., Ltd., and other investors
19-06-20
CI
Eone Diagnomics Genome Center Co.Ltd.(KOSDAQ:A245620) added to S&P Global BMI Index
18-12-24
CI
EONE-DIAGNOMICS Genome Center Announces the Release of Liquid Biopsy Screening Service
18-10-19
CI
Eone Diagnomics Genome Center Co.Ltd. acquired 49.9% stake in Cns Healthcare, Ltd from Kyungsook Im, Soonbae Cha and Yoonsoon Han.
18-09-29
CI
Eone Diagnomics Genome Center Co.Ltd. signed a definitive agreement to acquire 49.9% stake in Cns Healthcare, Ltd from Kyungsook Im, Soonbae Cha and Yoonsoon Han for KRW 19.7 billion.
18-09-03
CI
Eone Diagnomics Genome Center Co.Ltd. has completed an IPO in the amount of KRW 46.8 billion.
18-06-22
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
Eone Diagnomics Genome Center Co., Ltd. is a Korea-based company engaged in genetic analysis business. The Company is engaged in non-invasive prenatal tests (NIPT), newborn screening tests, ophthalmologist specialist genome analysis tests, customized disease prediction tests, and direct to consumer (DTC) genetic tests, among others. In addition, the Company is developing genome-related software.
More about the company
1st Jan change
Capi.
-0.72% 41.72M +16.03% 70.45B +2.22% 25.03B +7.11% 8.29B -2.98% 8.05B -20.55% 7.97B +3.91% 4.62B +17.12% 4.25B -1.24% 4.04B -3.44% 3.86B
Pharmaceuticals Wholesale
+951% of historical
More than 20 years
Our Experts
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1
EONE DIAGNOMICS GENOME CENTER CO., LTD. 
